-transparent.png){kind=logo}
N-Acetyltransferase phenotype has been determined in 109 control subjects and in 23 patients with bladder cancer. Sixty-two per cent of control, and 39% of patients with bladder cancer were phenotypically slow acetylators. This difference was not significant. N-Acetyltransferase phenotype is unlikely to be a major determinant in the development of bladder cancer in the Turkish population.
Related Publications
A E Karakaya, and
I Cok, and
S Sardas, and
O Gögüs, and
O S Sardas
September 2001,
Annals of the Academy of Medicine, Singapore,
A E Karakaya, and
I Cok, and
S Sardas, and
O Gögüs, and
O S Sardas
January 1987,
Neoplasma,
A E Karakaya, and
I Cok, and
S Sardas, and
O Gögüs, and
O S Sardas
January 2017,
Journal of toxicology and environmental health. Part A,
A E Karakaya, and
I Cok, and
S Sardas, and
O Gögüs, and
O S Sardas
February 1980,
Ugeskrift for laeger,
A E Karakaya, and
I Cok, and
S Sardas, and
O Gögüs, and
O S Sardas
June 2016,
Oncotarget,
A E Karakaya, and
I Cok, and
S Sardas, and
O Gögüs, and
O S Sardas
November 2013,
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
A E Karakaya, and
I Cok, and
S Sardas, and
O Gögüs, and
O S Sardas
June 1993,
Journal of the National Cancer Institute,
A E Karakaya, and
I Cok, and
S Sardas, and
O Gögüs, and
O S Sardas
January 1980,
Scandinavian journal of urology and nephrology,
A E Karakaya, and
I Cok, and
S Sardas, and
O Gögüs, and
O S Sardas
November 1982,
Lancet (London, England),
A E Karakaya, and
I Cok, and
S Sardas, and
O Gögüs, and
O S Sardas
August 1986,
Hinyokika kiyo. Acta urologica Japonica,
